These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 558109)

  • 21. Biofunctional evaluation of two hydrogen bonds stabilizing the beta-turn in the acyclic component of oxytocin.
    Roy U; Gazis D; Schwartz IL; Roy J
    Int J Pept Protein Res; 1983 Oct; 22(4):398-403. PubMed ID: 6654586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some biological properties of an "irreversible" antagonist of neurohypophyseal hormones, deamino-[Phe(4-BrCH2CONH)2]-oxytocin, and its isosteric analogue, deamino-[Phe(4-CH3CH2CONH)2]-oxytocin.
    Pliska V; Marbach P
    Eur J Pharmacol; 1978 Jun; 49(3):213-22. PubMed ID: 658139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actions of oxytocin and a long-acting carba oxytocin analog on the porcine myometrium in vitro and in vivo.
    Cort N; Einarsson S; Viring S
    Am J Vet Res; 1979 Mar; 40(3):430-2. PubMed ID: 475101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
    J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
    Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues).
    Barth T; Krejcí I; Kupková B; Jost K
    Eur J Pharmacol; 1973 Nov; 24(2):183-8. PubMed ID: 4797285
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of oxytocin-(1-6)-hexapeptide amide, vasopressin-(1-6)-hexapeptide amide and their deamino analogues.
    Krejcí I; Barth T; Kupková B; Fruhaufová L; Flegel M; Zaoral M
    Eur J Pharmacol; 1973 Nov; 24(2):179-82. PubMed ID: 4797284
    [No Abstract]   [Full Text] [Related]  

  • 29. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of threonine in position 4 in oxytocin and vasotocin analogs on the time course of uterotonic response.
    Barth T; Slaninová J; Lebl M; Hruby VJ
    Endocrinol Exp; 1987 Sep; 21(3):191-7. PubMed ID: 3117517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-response patterns of isolated rat uterus to neurohypophyseal peptides.
    Wahrenburg M; Koida M; Walter R; Pliska V
    Experientia; 1975 Sep; 31(9):1062-4. PubMed ID: 1236807
    [No Abstract]   [Full Text] [Related]  

  • 32. Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation.
    Lebl M; Hill P; Kazmierski W; Kárászová L; Slaninová J; Fric I; Hruby VJ
    Int J Pept Protein Res; 1990 Oct; 36(4):321-30. PubMed ID: 2079387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo simultaneous comparison of pressor and uterine responses to a single agonist (oxypressin) in estrous rats.
    Gazis D; Gonzalez G; Mendlowitz M
    Can J Physiol Pharmacol; 1987 Jan; 65(1):6-11. PubMed ID: 2952235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-response behavior on the isolated rat uterus of oxytocin analogs with modifications at binding sites.
    Smith CW; Chan S; Walter R
    J Pharmacol Exp Ther; 1977 Oct; 203(1):120-4. PubMed ID: 909047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
    Rath W
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oxytocin, prostaglandin F2 alpha and reproductive tract manipulations on uterine contractility in Holstein cows on days 0 and 7 of the estrous cycle.
    Cooper MD; Foote RH
    J Anim Sci; 1986 Jul; 63(1):151-61. PubMed ID: 3460978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil blockade of pressor and uterine responses to AVP-OT analogue, oxypressin.
    Gazis D; Gonzalez G; Mendlowitz M
    Am J Physiol; 1988 Jan; 254(1 Pt 2):R75-7. PubMed ID: 3337272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The design of effective in vivo antagonists of rat uterus and milk ejection responses to oxytocin.
    Sawyer WH; Haldar J; Gazis D; Seto J; Bankowski K; Lowbridge J; Turan A; Manning M
    Endocrinology; 1980 Jan; 106(1):81-91. PubMed ID: 7349976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The separate uterotonic and prostaglandin-releasing actions of oxytocin. Evidence and comparison with angiotensin and methacholine in the isolated rat uterus.
    Chan WY
    J Pharmacol Exp Ther; 1980 Jun; 213(3):575-9. PubMed ID: 7205617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of carbetocin, oxytocin and prostaglandin E2 and F2α on intrauterine pressure in cows in dioestrus and oestrus.
    Adler M; Bleul U
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2015; 43(1):15-24. PubMed ID: 25624033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.